FSA eligibility for semaglutide is governed by IRS Publication 502, not by individual provider marketing. We walk through the rule, the two payment paths (direct card at checkout vs reimbursement), how PlexusDx handles FSA-issued cards, and how compounded vs FDA-approved status affects substantiation.

Rybelsus (oral semaglutide) is FDA-approved for type 2 diabetes only — not for weight loss. See the real PIONEER weight numbers, the ~$998/month cash price, why insurance rarely covers off-label use, and how PlexusDx Semaglutide Oral ($289/mo+) and the Microdose GLP-1 Protocol ($129/mo) compare on cost and dose flexibility.

Oral semaglutide vs injectable semaglutide in 2026: Rybelsus, the new Wegovy pill, Ozempic, and Wegovy injection compared on dose, bioavailability, effectiveness, and cost — plus where PlexusDx Semaglutide Oral ($289/mo+), Semaglutide Injection ($189/mo), and Microdose GLP-1 Protocol ($129/mo flat) fit as cash-pay alternatives covering both pill and shot formats.

Mounjaro side effects from the FDA-approved label — common GI reactions (nausea, vomiting, diarrhea, constipation, abdominal pain), less common serious reactions (pancreatitis, gallbladder disease, acute kidney injury), and the boxed warning for thyroid C-cell tumors with MTC and MEN 2 contraindications. Plus how compounded tirzepatide protocol oversight from PlexusDx Tirzepatide Injection ($289/mo) and Tirzepatide Oral ($349/mo) compares, and where the Precision Peptide Genetic Test fits as $298 for GIPR, FTO, MC4R, and TCF7L2 baseline.

MEDVi, TrimRx, and PlexusDx all offer compounded GLP-1 programs, but only two publish a price you can check. This three-way comparison lines up same-medication pricing, introductory versus recurring charges, dose policies, included support, and cancellation terms as read September 22, 2026, and says plainly where the figures are unknown.

MEDVi, Ro and PlexusDx reach GLP-1 medication through three different access models: bundled compounded programs, a membership plus branded medication, and a flat all-inclusive compounded price. This three-way comparison separates medication identity, membership and medication charges, cash-pay process, and commitment terms so you can match each route to your priorities.

MEDVi, Remedy Meds and PlexusDx all offer compounded semaglutide and tirzepatide injections through telehealth, but their recurring prices, first-month structures, cancellation windows and refund rules differ. This three-way comparison lines up the published figures, marks what each provider leaves unpublished, and matches each program to a specific priority.

Three routes to tirzepatide work differently: MEDVi offers compounded tirzepatide and a separate branded Zepbound pathway, LillyDirect sells FDA-approved Zepbound at published self-pay prices with a prescription you bring, and PlexusDx offers compounded tirzepatide at one all-inclusive rate. This post compares access, charges and refill conditions as of September 22, 2026.

MEDVi, Hims and PlexusDx price GLP-1 care three different ways: an all-inclusive compounded program with a first-month rate, a monthly membership plus separately billed branded medication, and a flat all-inclusive monthly rate. This comparison lines up medication options, like-for-like totals, support, eligibility and cancellation terms.

MEDVi, Hers, and PlexusDx price GLP-1 care three different ways: MEDVi with an introductory month and a recurring refill rate, Hers with a membership billed apart from branded medication, and PlexusDx with one flat monthly price. This comparison uses each company's own pages as of September 22, 2026 and keeps compounded and branded products separate.

MEDVi vs Gala GLP-1 vs PlexusDx compared on verified 2026 pricing, compounded vs FDA-approved status, cancellation rules, and where a genetic baseline changes the dose decision before week one.

MEDVi's compounded semaglutide injection uses a lower first-month rate for new patients and a higher recurring refill rate. This guide separates the two, shows what the price includes, explains cancellation terms, and compares the same injection plan type against PlexusDx month-to-month and over 3, 6, and 12 billing cycles.

MEDVi sells two different oral routes under one banner: a compounded semaglutide dissolvable tablet priced about $70 a month over MEDVi's injection rate (no tablet total published), and a branded Wegovy pill pathway billed as membership plus medication. This review separates the two, explains what FDA approval does and does not cover, and compares them with PlexusDx oral options.

Is SHED legit? Yes — verified LLC, named pharmacy partners, 875+ reviews — but with a 2-month minimum and 72-hour cancellation cutoff. Compare SHED to PlexusDx Weight Management Protocols: month-to-month, no membership, with optional Precision Peptide Genetic Test before titration.

Florida residents can legally start GLP-1 telehealth in days under Statute §456.47. We compare MEDVi, Ro, Walgreens, and the PlexusDx Microdose GLP-1 Protocol from $129/mo — with a genetic baseline option no other Florida provider offers.

Constipation is one of the most common GLP-1 side effects — here's the food, fluid, movement, and dose-adjustment playbook that actually works, plus where the PlexusDx Microdose GLP-1 Protocol and Precision Peptide Genetic Test fit in.

A GLP-1 program under $300/month is real in 2026 if you pick a structure that doesn't reset in month two. Four PlexusDx protocols stay under the cap at every published dose tier: Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $189/mo (or $149/mo on the 6-month plan), Tirzepatide Injection at $289/mo (or $249/mo on the 6-month plan), and GLP-Squared at $289/mo (or $249/mo on the 3-month plan) — all cash-pay, all-inclusive, no membership.

What's common, what's serious, and how to manage GLP-1 side effects from FDA-labeled known information — including the boxed warning that applies to both semaglutide and tirzepatide, when to call your provider, and how PlexusDx structures titration and the optional Precision Peptide Genetic Test.

The honest list of GLP-1 options under $200/mo in April 2026 is much shorter than the ads suggest. PlexusDx Microdose GLP-1 Protocol at $129/mo flat is the lowest under-$200 option in this comparison, with PlexusDx Semaglutide Injection at $189/mo month-to-month (or $149/mo on the 6-month plan) as the lowest weekly compounded semaglutide path. FDA-approved Foundayo and the Wegovy pill start at $149/mo at lower doses but escalate with dose; most other “$199 GLP-1” ads are first-month-only promos that jump to $249–$349 on refill.

Wellness stipends typically reimburse GLP-1 programs through receipt upload, not direct employer billing. PlexusDx accepts payment from cards issued under wellness stipend and LSA programs (Compt, Forma, Espresa, Fringe, Benepass, PeopleKeep) and provides itemized receipts — but does not bill employers directly. Stipend eligibility depends on your employer's plan language, especially around “FDA-approved” vs “prescription medication” phrasing for compounded GLP-1s.

Pennsylvania Medicaid cut GLP-1 coverage for adult weight loss on January 1, 2026. This guide walks the legal cash-pay telehealth options that ship to PA, the compounded vs FDA-approved branded distinction, real annualized costs, and where PlexusDx Microdose GLP-1 ($129/mo), Semaglutide Injection ($189/mo), and Tirzepatide Injection ($289/mo) sit relative to Eden, Ro, TrimRx, Willow, and MEDVi — with the optional Precision Peptide Genetic Test adding pathway-level genetic context before week one.

Ohio's GLP-1 coverage fractured in 2025-2026 — State of Ohio employee plan, OSU Health Plan, and Ohio Medicaid all narrowed weight-loss GLP-1 access. This guide walks the cash-pay landscape, Ohio telehealth law, compounded vs FDA-approved options, and where PlexusDx Weight Management Protocols ($129/mo flat to) fit for Ohio residents.

NH Medicaid dropped GLP-1 weight-loss coverage on January 1, 2026. Here’s the cash-pay landscape for New Hampshire residents in 2026 — telehealth eligibility, real prices from $129 to $1,349/mo, compounded vs FDA-approved trade-offs, and where PlexusDx Weight Management Protocols fit.

Kentucky residents have three paths to GLP-1 weight-loss therapy in 2026: brand-name FDA-approved medication (Wegovy, Zepbound) at retail or Lilly Direct, in-person clinical care through systems like UK HealthCare Turfland, and cash-pay compounded telehealth. Kentucky Medicaid does not cover GLP-1 for weight loss. PlexusDx Weight Management Protocols ship to all 120 Kentucky counties from $129/mo flat with no membership fee.

The full 2026 GLP-1 cost map: Wegovy, Ozempic, Zepbound, and Mounjaro at branded list price; Lilly Direct and NovoCare manufacturer self-pay programs ($149–$499/mo); cash-pay compounded telehealth alternatives. PlexusDx Weight Management Protocols span $129/mo to $349/mo with all-inclusive pricing, no membership, all 50 states.

Foundayo's $149 headline is a one-month starter price — the real cash-pay year runs $3,338–$3,738 once you escalate. Compare PlexusDx Microdose GLP-1 ($129/mo flat), Semaglutide Oral ($289/mo), and Tirzepatide Oral ($349/mo) on annualized cost.

Foundayo costs $25/month with covered commercial insurance, $50/month on the Medicare GLP-1 Bridge, or $149-$289/mo self-pay through LillyDirect. Most commercial plans don't cover GLP-1s for weight loss in 2026. Compare cash-pay PlexusDx Weight Management Protocols — Microdose at $129/mo flat, Semaglutide Injection $189/mo, Tirzepatide Injection $289/mo — with no membership fee.

Eden semaglutide reviews split between a 4.4/5 Trustpilot score and BBB billing complaints. We verify Eden's real cost — $99/mo advertised, $198/mo all-in with the required membership (July 2026) — against PlexusDx Semaglutide Injection ($189/mo) and Microdose GLP-1 ($129/mo flat).

Eden vs Ro vs PlexusDx for cash-pay GLP-1: Eden's $298 advertised semaglutide runs $198/mo all-in with its required membership (verified July 2026); Ro pairs a $149/mo membership with branded medication billed on top; PlexusDx runs $129/mo to $349/mo month to month with an optional genetic baseline.